Latest

Pandorum Technologies Raises US$18 Million in Series B to Advance Global Access to Programmable Tissue Regenerative Therapies

Pandorum Technologies Raises US$18 Million in Series B to Advance Global Access to Programmable Tissue Regenerative Therapies

Pandorum Technologies, a biotechnology company pioneering programmable regenerative medicine, with operations in India and the United States, has announced the closing of  a US$18 million in Series B financing round, to advance the clinical development of its disease-modifying, tunable, exosome-based therapies, including Kuragenx, while scaling global manufacturing and expanding

By Shubham Kumar
Mankind Pharma’s Rajeev Juneja Headlines Nutrify Today’s ‘Legends of Lifesciences’ Series; Advocates for the ‘Pharmaceuticalization’ of Wellness

Mankind Pharma’s Rajeev Juneja Headlines Nutrify Today’s ‘Legends of Lifesciences’ Series; Advocates for the ‘Pharmaceuticalization’ of Wellness

Nutrify Today, the global catalyst for the nutraceutical industry, has premiered a landmark feature in its documentary series, Legends of Lifesciences, featuring Rajeev Juneja, Vice Chairman and Managing Director of Mankind Pharma. The documentary offers a rare, high-level perspective on the evolution of Indian healthcare, chronicling Juneja’s journey from

By Shubham Kumar